Elsevier

Nutrition

Volume 27, Issue 3, March 2011, Pages 276-281
Nutrition

Review
The role of hyperglycemia in acute illness: Supporting evidence and its limitations

https://doi.org/10.1016/j.nut.2010.07.013Get rights and content

Abstract

Hyperglycemia is common in acutely ill hospitalized patients and has been linked to poor outcomes, independent of pre-existing diabetes. Correction of hyperglycemia has been shown to decrease morbidity and mortality; however, establishing evidence-based guidelines has been challenging because insulin intervention studies have varied in the questions they have addressed, glucose levels studied, feeding regimen, and quality of methodology. This article reviews the findings and limitations of recent intervention studies that have addressed treatment of inpatient hyperglycemia with intravenous insulin infusion therapy. Discussion of underlying causes of hospital-related hyperglycemia and mechanisms explaining the deleterious effects of hyperglycemia and improved outcomes with insulin intervention are described. Current guidelines from various professional organizations recommend treatment of inpatient hyperglycemia, although exact glycemic targets and identification of which patient subsets will receive greatest benefit from glucose lowering remain an area of ongoing research.

Introduction

Hyperglycemia is common during acute illness in patients with and without diabetes. Although once considered an adaptive response to physiologic stress, a substantial accumulation of evidence now links hyperglycemia in hospitalized patients to poor outcomes. Furthermore, correcting hyperglycemia has been shown to decrease morbidity and mortality. Current guidelines from various professional organizations recommend the treatment of inpatient hyperglycemia regardless of prior diagnosis of diabetes [1], [2], [3]; however, the exact glycemic targets and widespread implementation of glucose-lowering practices remain controversial. The purpose of this article is to review the evidence regarding consequences of hyperglycemia and treatment targets in hospitalized patients and to describe potential mechanisms that cause abnormal glucose metabolism in acutely ill populations.

Section snippets

Hospital-related hyperglycemia and adverse outcomes

Hyperglycemia has been associated with increased mortality and morbidity for a variety of medical conditions and patient populations [4], [5]. Collectively, numerous studies conducted in the settings of acute myocardial infarction [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], stroke [17], [18], critical illness [19], [20], coronary artery bypass graft surgery [21], [22], trauma [5], [23], [24], [25], [26], [27], cerebral endarterectomy [28], congestive heart failure [29], [30],

Randomized controlled trials of intravenous insulin intervention for hyperglycemia

The strongest evidence to support normalizing blood glucose in the intensive care unit (ICU) remains the Leuven study of 1,548 surgical patients in the ICU that examined the effects of continuous insulin infusion to achieve a target glucose range of 80–110 mg/dL. In this study, Van den Berghe et al. [38] demonstrated substantial decreases in hospital and ICU mortality, bloodstream infections, renal insufficiency, and need for mechanical ventilation and blood transfusions. A subsequent study

Meta-analyses of intravenous insulin treatment for hyperglycemia

Initial meta-analyses aimed at assessing the benefits and risks of glucose control in critically ill adults include a diverse array of trials with different target glucose levels and insulin preparations [45], [46]. Subsequent meta-analyses have been able to analyze data derived from studies examining normoglycemia, including large trials such as NICE-SUGAR. One recent systematic review is particularly informative because it includes only trials in which glucose control was the goal and

Limitations of trials and systematic reviews of insulin therapy in hospitalized patients

A consistent factor limiting studies of intensive glycemic control is that many have been terminated early due to excessive hypoglycemia. Hypoglycemia is the most common complication associated with inpatient insulin therapy. Risk of hypoglycemia remains a barrier to the implementation of inpatient diabetes care strategies and the increased likelihood of hypoglycemia associated with glucose-lowering intervention extends to the setting of clinical trials [42], [44], [49].

Perhaps equally relevant

Hypoglycemia and glucose variability

Hypoglycemia is an important and common adverse event related to inpatient glycemic control, the consequences of which are still unclear [57], [58], [59]. In a recent meta-analysis by Griesdale et al. [47], among the trials that reported hypoglycemia, the pooled relative risk with intensive insulin therapy was 6.0 (95% confidence interval 4.5–8.0). A retrospective chart review of 863 pediatric patients in the ICU showed that 9.7% had at least one blood glucose measurement lower than 60 mg/dL in

Causes of hospital-related hyperglycemia

Hyperglycemia is common in hospitalized patients and is not limited to those with a known diagnosis of diabetes. Stress-induced hyperglycemia is a term used to describe a transient physiologic response to the stress of an acute illness or injury. During illness, the action of counter-regulatory hormones such as glucagon, catecholamines, growth hormone, glucocorticoids, and cytokines result in increased hepatic gluconeogenesis and insulin resistance [69]. However, stress-induced hyperglycemia

Mechanisms underlying detrimental effects of hyperglycemia and improved outcomes with insulin intervention

The detrimental effects of hyperglycemia in the context of acute illness are postulated to act through a variety of mechanisms. Fluid and electrolyte shifts contribute to direct toxicity to vulnerable tissues. Additional deleterious factors include: immune dysfunction caused by impaired reactivity of leukocyte and mononuclear cell responsiveness, increased inflammatory response with release of reactive oxygen species, and promotion of coagulation associated with abnormal endothelial function

Conclusion

Hyperglycemia in hospitalized patients is common and associated with adverse outcomes including increased mortality. Treatment of hyperglycemia has proven beneficial, however, establishing evidence-based guidelines has been challenging because insulin infusion interventions have varied in the questions they have addressed, glucose levels studied, and quality of methodology. Ongoing research of the mechanisms underlying the detrimental effects of hyperglycemia and the beneficial effects of

References (104)

  • S.M. Curkendall et al.

    Economic and clinical impact of inpatient diabetic hypoglycemia

    Endocr Pract

    (2009)
  • S.Y. Yang et al.

    Clinical significance of admission hyperglycemia and factors related to it in patients with acute severe head injury

    Surg Neurol

    (1995)
  • D.J. Husband et al.

    “Stress” hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes?

    Lancet

    (1983)
  • A. Norhammar et al.

    Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

    Lancet

    (2002)
  • S. Arora et al.

    High incidence of impaired glucose regulation in patients with no known history of diabetes mellitus but with hyperglycemia after undergoing a cardiac surgical procedure

    Endocr Pract

    (2009)
  • M.E. Halkos et al.

    Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery

    Ann Thorac Surg

    (2008)
  • N.W. Cheung et al.

    Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus

    J Diabetes Complications

    (2006)
  • M. Albareda et al.

    Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy

    Metabolism

    (2005)
  • K.C. McCowen et al.

    Stress-induced hyperglycemia

    Crit Care Clin

    (2001)
  • P. Dandona et al.

    Insulin as an anti-inflammatory and antiatherogenic modulator

    J Am Coll Cardiol

    (2009)
  • C.S. Gray et al.

    Glucose–potassium–insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)

    Lancet Neurol

    (2007)
  • E.S. Moghissi et al.

    American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control

    Diabetes Care

    (2009)
  • R.P. Dellinger et al.

    Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

    Crit Care Med

    (2008)
  • B.G. Fahy et al.

    Glucose control in the intensive care unit

    Crit Care Med

    (2009)
  • G. Van den Berghe et al.

    Insulin therapy protects the central and peripheral nervous system of intensive care patients

    Neurology

    (2005)
  • C. Bauters et al.

    Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients

    Eur Heart J

    (2007)
  • T. Ainla et al.

    The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes

    Diabet Med

    (2005)
  • A. Goyal et al.

    Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study

    Eur Heart J

    (2006)
  • S. Hadjadj et al.

    Prognostic value of admission plasma glucose and HbA in acute myocardial infarction

    Diabet Med

    (2004)
  • M. Suleiman et al.

    Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study

    Circulation

    (2005)
  • J.R. Timmer et al.

    Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes

    QJM

    (2006)
  • M. Kosiborod et al.

    Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

    Circulation

    (2005)
  • S.E. Capes et al.

    Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

    Stroke

    (2001)
  • A. Bruno et al.

    Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

    Neurology

    (2002)
  • S.J. Finney et al.

    Glucose control and mortality in critically ill patients

    JAMA

    (2003)
  • A.P. Furnary et al.

    Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures

    Ann Thorac Surg

    (1999)
  • S.H. Golden et al.

    Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes

    Diabetes Care

    (1999)
  • A.M. Laird et al.

    Relationship of early hyperglycemia to mortality in trauma patients

    J Trauma

    (2004)
  • M. Vogelzang et al.

    Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients

    J Trauma

    (2006)
  • J. Sung et al.

    Admission hyperglycemia is predictive of outcome in critically ill trauma patients

    J Trauma

    (2005)
  • G.V. Bochicchio et al.

    Persistent hyperglycemia is predictive of outcome in critically ill trauma patients

    J Trauma

    (2005)
  • J.L. Sperry et al.

    Characterization of persistent hyperglycemia: what does it mean postinjury?

    J Trauma

    (2009)
  • M.J. McGirt et al.

    Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy

    Neurosurgery

    (2006)
  • J.D. Newton et al.

    Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure

    Heart

    (2006)
  • A. Barsheshet et al.

    Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure

    Arch Intern Med

    (2006)
  • E.H. Baker et al.

    Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease

    Thorax

    (2006)
  • A. Szerszen et al.

    Glucose control in the hospitalized elderly—a concern not just for patients with diabetes

    Geriatrics

    (2009)
  • I. Sleiman et al.

    Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit

    J Am Geriatr Soc

    (2008)
  • L.S. Kao et al.

    Hyperglycemia and morbidity and mortality in extremely low birth weight infants

    J Perinatol

    (2006)
  • V. Srinivasan et al.

    Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children

    Pediatr Crit Care Med

    (2004)
  • Cited by (34)

    • Regulatory aspects: Toxicity and safety

      2022, Advances in Nanotechnology-Based Drug Delivery Systems
    • Stability of the insulin-glucose feedback loop in Glucosafe: A comparison of pancreas models

      2015, Biomedical Signal Processing and Control
      Citation Excerpt :

      Stress-induced hyperglycaemia is a common response to altered metabolism induced by critical illness and has been associated with increased morbidity and mortality [1,2].

    • Metabolic self-destruction in critically ill patients: Origins, mechanisms and therapeutic principles

      2014, Nutrition
      Citation Excerpt :

      Compared with physiological adaptions to variations in food supply or composition, however, the metabolic responses to a severe disturbance of homeostasis are not nearly as impressive, and may be regarded as middling at best. Indeed, a significant portion of morbidity and mortality that is observed in response to severe shock, injury, or in infection, most likely is mediated by endogenous secondary metabolic reactions impairing immunologic functions and causing cachexia [2–4]. Within these undesired metabolic reactions, two phenomena are of particular clinical importance: an exaggerated hepatic glucose production, which is associated with hyperglycemia and insulin resistance, and a progressive loss of muscle mass.

    View all citing articles on Scopus
    View full text